The Food and Drug Administration (FDA) could authorize emergency use of antibody-rich blood plasma from recovered COVID-19 patients to treat people infected with the coronavirus as early as next week, the Wall Street Journal reported on Wednesday, citing people familiar with the matter.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
WSJ News Exclusive | FDA Nears Decision Authorizing Covid-19 Treatment With Convalescent PlasmaThe FDA is nearing a decision to authorize emergency use of antibody-rich blood plasma from recovered Covid-19 patients for treating people infected with the coronavirus
続きを読む »
FDA authorizes first COVID-19 test for people without symptomsNew research finds similar levels of the virus in people who test positive with and without symptoms.
続きを読む »
Andy Cohen calls FDA rules on gay men donating plasma for COVID-19 ‘discriminatory’COVID-19 survivor Andy Cohen speaks out on being prohibited from donating plasma due to decades-old FDA guidelines limiting gay and bisexual men from donating blood.
続きを読む »
Roche trial of drug to treat COVID-19-related pneumonia failsA late-stage clinical trial of Roche's Actemra/RoActemra drug to treat patients hospitalised with severe COVID-19-related pneumonia failed, the drugmaker said on Wednesday.
続きを読む »
Trump doubles down on defense of hydroxychloroquine to treat COVID-19 despite efficacy concernsAsked about video he shared featuring figure blasting masks recommendations and touting hydroxychloroquine, Pres. Trump said, 'I thought her voice was an important voice, but I know nothing about her.' Pressed further, Trump left the briefing room.
続きを読む »